Collection, Extraction and Detection Solutions for COVID‐19
Since 1994, Zymo Research has been led by a vision to have a positive impact in the biomedical field and to contribute to the greater good of humanity. To assist with pandemic response, we have supported countless COVID-19 testing workflows with an FDA EUA SARS-CoV-2 workflow that consists of sample collection, sample preparation and real-time RT-PCR analysis. Additionally, we offer the first 510(k)-cleared transport medium for COVID-19 testing and COVID-19 variant sequencing service.
The Gold Standard for Epigenetics Products
Zymo Research, known as “the Epigenetics Company,” is dedicated to developing innovative epigenetics products that provide highest efficiency ensuring reliable data, and simplified workflows to benefit automated sample processing for relative clinical applications. The EZ DNA Methylation collection of kits remain the most trusted as well as the most cited technologies available for DNA methylation analysis. These innovative products are ideal for studies on cancer, aging, developmental biology, and other emerging fields from bench to bedside.
Microbiomics Made Simple
NGS-based microbiome measurements are prone to bias and errors without proper tools and handling. Zymo Research is determined to provide the best tools and reagents to help researchers improve the accuracy of microbiome measurements. These include the first commercial microbiome standard, ambient temperature microbiome sample stabilization, DNA/RNA extraction kits featuring unbiased microbial lysis, and microbiome analysis services with state-of-the-art bioinformatics included.